4.6 Article

Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade

Journal

CANCER IMMUNOLOGY RESEARCH
Volume 2, Issue 5, Pages 410-422

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2326-6066.CIR-13-0171

Keywords

-

Funding

  1. U.S. NIH [R01AI081848, R01AI071078, R43CA153669]
  2. Melanoma Research Alliance
  3. Cancer Research Institute
  4. Programme for Advanced Medical Education
  5. ACS grant [RSG-11-057-01-LIB]
  6. NIH [R01 NS045937, P01 AI07378]
  7. NYU Cancer Institute NCI Cancer Center Support Grant [5 P30 CA 016087-27]
  8. Marc Jacobs Campaign

Ask authors/readers for more resources

The immunoregulatory protein T-cell immunoglobulin-and mucin-domain-containing molecule-3 (Tim-3) mediates T-cell exhaustion and contributes to the suppression of immune responses in both viral infections and tumors. Tim-3 blockade reverses the exhausted phenotype of CD4(+) and CD8(+) T cells in several chronic diseases, including melanoma. Interestingly, natural killer (NK) cells constitutively express Tim-3; however, the role of Tim-3 in modulating the function of these innate effector cells remains unclear, particularly in human diseases. In this study, we compared the function of Tim-3 in NK cells from healthy donors and patients with metastatic melanoma. NK cells from the latter were functionally impaired/exhausted, and Tim-3 blockade reversed this exhausted phenotype. Moreover, Tim-3 expression levels were correlated with the stage of the disease and poor prognostic factors. These data indicate that Tim-3 can function as an NK-cell exhaustion marker in advanced melanoma and support the development of Tim-3-targeted therapies to restore antitumor immunity. (C) 2014 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available